4.7 Article

Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor

期刊

VETERINARY MICROBIOLOGY
卷 237, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.vetmic.2019.108398

关键词

Feline infectious peritonitis virus; 3C-like protease; Antivirals; Genetic barrier; Feline coronavirus; Resistance

资金

  1. National Institutes of Health [RO1 AI130092]
  2. Morris Animal Foundation [D14FE-012, D16FE-512]

向作者/读者索取更多资源

Feline infectious peritonitis (FIP) is a highly fatal disease caused by a virulent feline coronavirus in domestic and wild cats. We have previously reported the synthesis of potent coronavirus 3C-like protease (3CLpro) inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with FIP. In this study, we studied the effect of the amino acid changes in 3CLpro of feline coronavirus from a feline patient who received antiviral treatment for prolonged duration. We generated recombinant 3CLpro containing the identified amino acid changes (N25S, A252S or K260 N) and determined their susceptibility to protease inhibitors in the fluorescence resonance energy transfer assay. The assay showed that N25S in 3CLpro confers a small change (up to 1.68-fold increase in the 50% inhibitory concentration) in susceptibility to GC376, but other amino acid changes do not affect susceptibility. Modelling of 3CLpro carrying the amino acid changes was conducted to probe the structural basis for these findings. The results of this study may explain the observed absence of clinical resistance to the long-term antiviral treatment in the patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease

Chamandi S. Dampalla, Yunjeong Kim, Naemi Bickmeier, Athri D. Rathnayake, Harry Nhat Nguyen, Jian Zheng, Maithri M. Kashipathy, Matthew A. Baird, Kevin P. Battaile, Scott Lovell, Stanley Perlman, Kyeong-Ok Chang, William C. Groutas

Summary: Novel inhibitors have been synthesized that effectively inhibit coronavirus protease, showing potential for treating COVID-19 and providing a means to access new chemical space and optimize pharmacological activity.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Multidisciplinary Sciences

Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection

Chamandi S. Dampalla, Jian Zheng, Krishani Dinali Perera, Lok-Yin Roy Wong, David K. Meyerholz, Harry Nhat Nguyen, Maithri M. Kashipathy, Kevin P. Battaile, Scott Lovell, Yunjeong Kim, Stanley Perlman, William C. Groutas, Kyeong-Ok Chang

Summary: The study presents a series of deuterated 3CLpro inhibitor variants, particularly GC376, showing potent antiviral effects against SARS-CoV-2 in cell-based and enzyme assays. Treatment with a deuterated derivative of GC376 increased survival rates in lethally infected mice and reduced lung virus titers and histopathological changes. Structural investigation revealed promising potential of deuterated GC376 variants as effective antiviral agents against SARS-CoV-2 through their binding interactions with 3CLpro.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemical Research Methods

Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2

Erin E. Schirtzinger, Yunjeong Kim, A. Sally Davis

Summary: The SARS-CoV-2 pandemic has renewed interest in human coronaviruses that cause the common cold. This study investigated the growth parameters of HCoV-OC43 in different cell lines, finding that HCoV-OC43 grown in MRC-5 cells reached a peak titer at two days post infection, while in HRT-18 cells, it required six days.

JOURNAL OF VIROLOGICAL METHODS (2022)

Article Chemistry, Medicinal

Structure-Guided Design of Potent Spirocyclic Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3C-like Protease

Chamandi S. Dampalla, Athri D. Rathnayake, Anushka C. Galasiti Kankanamalage, Yunjeong Kim, Krishani Dinali Perera, Harry Nhat Nguyen, Matthew J. Miller, Trent K. Madden, Hunter R. Picard, Hayden A. Thurman, Maithri M. Kashipathy, Lijun Liu, Kevin P. Battaile, Scott Lovell, Kyeong-Ok Chang, William C. Groutas

Summary: The 3C-like protease (3CLpro) of SARS-CoV-2 has been validated as an effective target for developing therapeutics. Highly potent inhibitors have been successfully designed based on structure-guided design, and their mechanism of action has been established using high-resolution cocrystal structures.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Microbiology

Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization

Yunjeong Kim, Natasha N. Gaudreault, David A. Meekins, Krishani D. Perera, Dashzeveg Bold, Jessie D. Trujillo, Igor Morozov, Chester D. McDowell, Kyeong-Ok Chang, Juergen A. Richt

Summary: This study reveals the host range of SARS-CoV-2 and the effects of recently emergent S protein substitutions on viral entry, virus replication, and antibody-mediated viral neutralization, with particular emphasis on the significant impact of substitutions in the S protein of the Omicron variant on antibody neutralization.

MICROBIOLOGY SPECTRUM (2022)

Article Microbiology

Potent Protease Inhibitors of Highly Pathogenic Lagoviruses: Rabbit Hemorrhagic Disease Virus and European Brown Hare Syndrome Virus

Krishani Dinali Perera, David Johnson, Scott Lovell, William C. Groutas, Kyeong-Ok Chang, Yunjeong Kim

Summary: This study investigated the characteristics of lagoviruses such as Rabbit hemorrhagic disease and European brown hare syndrome, and their impact on animals. The key role of the 3C-like protease (3CLpro) in virus replication was also explored. The study identified potential antiviral drugs that target this protease, providing hope for the development of treatments for lagoviruses.

MICROBIOLOGY SPECTRUM (2022)

Article Virology

SARS-CoV-2 Omicron (B.1.1.529) Infection of Wild White-Tailed Deer in New York City

Kurt J. Vandegrift, Michele Yon, Meera Surendran Nair, Abhinay Gontu, Santhamani Ramasamy, Saranya Amirthalingam, Sabarinath Neerukonda, Ruth H. Nissly, Shubhada K. Chothe, Padmaja Jakka, Lindsey LaBella, Nicole Levine, Sophie Rodriguez, Chen Chen, Veda Sheersh Boorla, Tod Stuber, Jason R. Boulanger, Nathan Kotschwar, Sarah Grimke Aucoin, Richard Simon, Katrina L. Toal, Randall J. Olsen, James J. Davis, Dashzeveg Bold, Natasha N. Gaudreault, Krishani Dinali Perera, Yunjeong Kim, Kyeong-Ok Chang, Costas D. Maranas, Juergen A. Richt, James M. Musser, Peter J. Hudson, Vivek Kapur, Suresh V. Kuchipudi

Summary: There is growing evidence of SARS-CoV-2 spillover from humans to various animal species, including deer. This study investigated the active and asymptomatic infection of the Omicron variant in free-ranging deer in New York City. The findings revealed that a small number of deer had been exposed to SARS-CoV-2, with two deer showing evidence of reinfection or early seroconversion. This suggests that variants of concern are still circulating and may reestablish transmission cycles in US deer populations, highlighting the need for a coordinated One Health response.

VIRUSES-BASEL (2022)

Article Chemistry, Medicinal

Broad-Spectrum Cyclopropane-Based Inhibitors of Coronavirus 3C- like Proteases: Biochemical, Structural, and Virological Studies

Chamandi S. Dampalla, Harry Nhat Nguyen, Athri D. Rathnayake, Yunjeong Kim, Krishani Dinali Perera, Trent K. Madden, Hayden A. Thurman, Alexandra J. Machen, Maithri M. Kashipathy, Lijun Liu, Kevin P. Battaile, Scott Lovell, Kyeong-Ok Chang, William C. Groutas

Summary: The emergence of SARS-CoV-2 has led to the urgent need for effective countermeasures, such as vaccines and direct-acting antivirals. This study focuses on the design of highly potent inhibitors for SARS-CoV-2 and other related coronaviruses. The results show promising candidates with low cytotoxicity and high potency for further development as broad-spectrum antivirals.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Article Multidisciplinary Sciences

The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2

Ruiqi Huang, Gabrielle Warner Jenkins, Yunjeong Kim, Robyn L. Stanfield, Amrinder Singh, Maria Martinez-Yamout, Gerard J. Kroon, Jonathan L. Torres, Abigail M. Jackson, Abigail Kelley, Namir Shaabani, Baisen Zeng, Michael Bacica, Wen Chen, Christopher Warner, Jasmina Radoicic, Joongho Joh, Krishani Dinali Perera, Huldah Sang, Tae Kim, Jianxiu Yao, Fangzhu Zhao, Devin Sokd, Dennis R. Burton, Jeff Allen, William Harriman, Waithaka Mwangi, Donghoon Chung, John R. Teijaro, Andrew B. Ward, H. Jane Dyson, Peter E. Wright, Ian A. Wilson, Kyeong-Ok Chang, Duncan Mcgregor, Vaughn V. Smider

Summary: Antibodies derived from cows have the potential to be a new class of therapeutics, capable of neutralizing various SARS-CoV-2 variants and providing protection against disease.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

暂无数据